Host Defenses Against Htlv I and II

Baron, Samuel

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 3U01CA040764-03S1
• Application #: 3548672
• Study Section: (SRC)
• Project Start: 1985-09-30
• Project End: 1989-07-31
• Budget Start: 1988-08-01
• Budget End: 1989-07-31
• Support Year: 3
• Fiscal Year: 1988

Institution

• Name: University of Texas Medical Br Galveston
• Type: Schools of Medicine
• DUNS #: 041367053
• City: Galveston
• State: TX
• Country: United States
• Zip Code: 77555

Publications

Sarzotti, M; Klimpel, G R; Baron, S (1989) Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells. Nat Immun Cell Growth Regul 8:66-75

Sullivan, M L; Niesel, D W; Coppenhaver, D H et al. (1987) Characterization of an antiviral agent from primary murine fibroblast cultures: murine tissue culture CVI. J Biol Regul Homeost Agents 1:126-32

Hughes, T K; Baron, S (1987) A large component of the antiviral activity of mouse interferon-gamma may be due to its induction of interferon-alpha. J Biol Regul Homeost Agents 1:29-32